Literature DB >> 17093942

High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study.

L Prompers1, M Huijberts, J Apelqvist, E Jude, A Piaggesi, K Bakker, M Edmonds, P Holstein, A Jirkovska, D Mauricio, G Ragnarson Tennvall, H Reike, M Spraul, L Uccioli, V Urbancic, K Van Acker, J van Baal, F van Merode, N Schaper.   

Abstract

AIMS/HYPOTHESIS: Large clinical studies describing the typical clinical presentation of diabetic foot ulcers are limited and most studies were performed in single centres with the possibility of selection of specific subgroups. The aim of this study was to investigate the characteristics of diabetic patients with a foot ulcer in 14 European hospitals in ten countries.
METHODS: The study population included 1,229 consecutive patients presenting with a new foot ulcer between 1 September 2003 and 1 October 2004. Standardised data on patient characteristics, as well as foot and ulcer characteristics, were obtained. Foot disease was categorised into four stages according to the presence or absence of peripheral arterial disease (PAD) and infection: A: PAD -, infection -; B: PAD -, infection +; C: PAD +, infection -; D: PAD +, infection +.
RESULTS: PAD was diagnosed in 49% of the subjects, infection in 58%. The majority of ulcers (52%) were located on the non-plantar surface of the foot. With regard to severity, 24% had stage A, 27% had stage B, 18% had stage C and 31% had stage D foot disease. Patients in the latter group had a distinct profile: they were older, had more non-plantar ulcers, greater tissue loss and more serious comorbidity. CONCLUSIONS/
INTERPRETATION: According to our results in this European cohort, the severity of diabetic foot ulcers at presentation is greater than previously reported, as one-third had both PAD and infection. Non-plantar foot ulcers were more common than plantar ulcers, especially in patients with severe disease, and serious comorbidity increased significantly with increasing severity of foot disease. Further research is needed to obtain insight into the clinical outcome of these patients.

Entities:  

Mesh:

Year:  2006        PMID: 17093942     DOI: 10.1007/s00125-006-0491-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Limb salvage in diabetics with foot ulcers.

Authors:  K Larsen; P Holstein; T Deckert
Journal:  Prosthet Orthot Int       Date:  1989-08       Impact factor: 1.895

2.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

Authors:  S D Ramsey; K Newton; D Blough; D K McCulloch; N Sandhu; G E Reiber; E H Wagner
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

3.  The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb.

Authors:  J T Raymakers; A J Houben; J J van der Heyden; J H Tordoir; P J Kitslaar; N C Schaper
Journal:  Diabet Med       Date:  2001-03       Impact factor: 4.359

4.  An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.

Authors:  Lawrence Harkless; Jack Boghossian; Richard Pollak; Wayne Caputo; Adrian Dana; Sharon Gray; David Wu
Journal:  Surg Infect (Larchmt)       Date:  2005       Impact factor: 2.150

5.  The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers.

Authors:  S O Oyibo; E B Jude; I Tarawneh; H C Nguyen; D G Armstrong; L B Harkless; A J Boulton
Journal:  Diabet Med       Date:  2001-02       Impact factor: 4.359

6.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.

Authors:  G E Reiber; L Vileikyte; E J Boyko; M del Aguila; D G Smith; L A Lavery; A J Boulton
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

7.  Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial.

Authors:  Michael J Mueller; David R Sinacore; Mary Kent Hastings; Michael J Strube; Jeffrey E Johnson
Journal:  J Bone Joint Surg Am       Date:  2003-08       Impact factor: 5.284

Review 8.  The burden of diabetic foot ulcers.

Authors:  G E Reiber; B A Lipsky; G W Gibbons
Journal:  Am J Surg       Date:  1998-08       Impact factor: 2.565

9.  Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy.

Authors:  A J Boulton; F A Gries; J A Jervell
Journal:  Diabet Med       Date:  1998-06       Impact factor: 4.359

10.  Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial.

Authors:  M J Mueller; J E Diamond; D R Sinacore; A Delitto; V P Blair; D A Drury; S J Rose
Journal:  Diabetes Care       Date:  1989-06       Impact factor: 19.112

View more
  158 in total

1.  Intraoperative fluorescence vascular angiography: during tibial bypass.

Authors:  Diana Perry; Manish Bharara; David G Armstrong; Joseph Mills
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

2.  Hyperbaric oxygen in the management of chronic diabetic foot ulcers.

Authors:  Andrew J M Boulton
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

3.  Operative Intervention Does Not Change Pain Perception in Patients With Diabetic Foot Ulcers.

Authors:  Olivia V Waldman; Stephanie P Hao; Jeff R Houck; Nicolette J Lee; Judith F Baumhauer; Irvin Oh
Journal:  Clin Diabetes       Date:  2020-04

Review 4.  Topical antimicrobial agents for treating foot ulcers in people with diabetes.

Authors:  Jo C Dumville; Benjamin A Lipsky; Christopher Hoey; Mario Cruciani; Marta Fiscon; Jun Xia
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

5.  Increasing SBP variability is associated with an increased risk of developing incident diabetic foot ulcers.

Authors:  Meghan B Brennan; Marylou Guihan; Elly Budiman-Mak; Hyojung Kang; Jennifer M Lobo; Bryn L Sutherland; Nicholas Emanuele; Elbert S Huang; Min-Woong Sohn
Journal:  J Hypertens       Date:  2018-11       Impact factor: 4.844

6.  Neutrophil Extracellular Traps Are Markers of Wound Healing Impairment in Patients with Diabetic Foot Ulcers Treated in a Multidisciplinary Setting.

Authors:  Shuofei Yang; Zhichun Gu; Can Lu; Ting Zhang; Xiangjiang Guo; Guanhua Xue; Lan Zhang
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-12-06       Impact factor: 4.730

7.  Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing.

Authors:  Michael Loesche; Sue E Gardner; Lindsay Kalan; Joseph Horwinski; Qi Zheng; Brendan P Hodkinson; Amanda S Tyldsley; Carrie L Franciscus; Stephen L Hillis; Samir Mehta; David J Margolis; Elizabeth A Grice
Journal:  J Invest Dermatol       Date:  2016-08-24       Impact factor: 8.551

8.  Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes.

Authors:  Magnus Löndahl; Per Katzman; Anders Nilsson; Christer Hammarlund
Journal:  Diabetes Care       Date:  2010-05       Impact factor: 19.112

9.  A classification of diabetic foot infections using ICD-9-CM codes: application to a large computerized medical database.

Authors:  Benjamin G Fincke; Donald R Miller; Robin Turpin
Journal:  BMC Health Serv Res       Date:  2010-07-06       Impact factor: 2.655

10.  A questionnaire for determining prevalence of diabetes related foot disease (Q-DFD): construction and validation.

Authors:  Caroline A Brand; Peter G Colman; Donald A Campbell; Shan M Bergin
Journal:  J Foot Ankle Res       Date:  2009-11-25       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.